• Astellas Pharma Inc. (YPH.BE)'s Subsidiary Urogenix Inc. Shutting Down, 13 Scientists and Staff Affected More...

• KV Pharmaceutical Seeks Chap. 11 More...

• Proteros biostructures GmbH Announces Successful Close of 5 Million Euros More...

• GlaxoSmithKline (GSK) Completes $3.6 Billion Takeover of Human Genome Sciences, Inc. (HGSI) More...

• BC Partners to Acquire Aenova From Bridgepoint More...

• Kamada Ltd. (KMDA.TA) and Chiesi Farmaceutici SpA Enter into a Strategic Agreement for Up to $60 Million More...

• PharmaEngine, Inc. Nabs Rights to Nanobiotix's Nanoparticle Radiotherapy Booster for Up to $57 Million More...

• Novartis AG (NVS) Gets Immune-Cell Cancer Therapy in University of Pennsylvania Pact More...

• Tekmira Pharmaceuticals Corporation Provides Update on Collaboration With U.S. Government's TMT Program More...

• ACCU-BREAK Pharmaceuticals, Inc. Enters Into a Product Development and License Agreement With Alembic Pharmaceuticals Limited More...

• Nile Therapeutics, Inc. Promotes Darlene Horton, M.D., to Chief Executive Officer and Director More...

• Perreault Will Move Up to CEO of CSL Behring More...

• BioLargo, Inc. (BLGO.PK) Adds Wound Management Expert and Former VP at Smith & Nephew Inc. (SNN), Tanya Rhodes, to Its Team More...

• Champions Oncology, Inc. (CSBR) Reports Resignation of Director More...

• Eclipse Therapeutics, Inc., Sorrento Valley-Based Biotech Developing Innovative Cancer Therapeutics that Target Cancer Stem Cells, Appoints Patrick M. O'Connor, Ph.D. to Scientific Advisory Board More...

• Accellent Announces Timing of Second Quarter 2012 Earnings Release and Conference Call More...

• Celsion Corporation (CLN) to Hold Second Quarter 2012 Financial Results Conference Call on Tuesday, August 14, 2012 More...

• Cleveland Biolabs Inc. (CBLI) Reports Second Quarter 2012 Financial Results and Development Progress More...

• Cumberland Pharmaceuticals (CPIX) Reports Second Quarter 2012 Financial Results More...

• Depomed, Inc. (DEPO) Reports Second Quarter Financial Results More...

• Teva Pharmaceutical Industries Limited (TEVA) Subpoenaed Over Foreign Bribes More...

• U.S. Appeals Court Tosses Momenta Pharmaceuticals, Inc. (MNTA) Injunction Against Generic Lovenox More...

• CoreRx Opens Brand New 35,000 sq. ft. State-of-the-Art Facility More...

• FDA OKs First Generic Copies of Merck & Co., Inc. (MRK)'s Singulair More...

• Medivation, Inc. (MDVN) and Astellas Pharma Inc. (YPH.BE) Get PDUFA Date for Prostate Cancer Drug More...

• OXiGENE (OXGN) Announces Phase 2 Ovarian Cancer Trial of ZYBRESTAT® Plus Bevacizumab Achieves Important Interim Safety Objective More...

• TWi Pharmaceuticals, Inc. Announces Positive Phase IIb Clinical Trial Results of AC-201 in Patients With Type 2 Diabetes. More...

• Cellceutix (CTIX) Reports Its Very Novel Anti-Cancer Agent, Kevetrin, at Dana-Farber Cancer Institute for Start of Clinical Trials More...

• Alnylam Pharmaceuticals (ALNY) Presents New Data From Its Conjugate Delivery Platform, Enabling Subcutaneous Administration of RNAi Therapeutics With Wide Therapeutic Index More...

• Rexahn Pharmaceuticals, Inc. Completes Exploratory Phase I Clinical Study of RX-3117 More...

• The Way Your Pupils Dilate May Show Sexual Preference, Cornell University Study More...

• Carbon Monoxide's Damaging Role in Heart Rhythm Found, Leeds University Study More...

• Memory Improves for Older Adults Using Computerized Brain Fitness Program,University of California, Los Angeles (UCLA) Study More...

• Bilingualism "Can Increase Mental Agility," University of Strathclyde Study More...

• Honey May Ease Nighttime Coughing in Kids, Tel Aviv University Study More...

• Biostar Pharmaceuticals, Inc. (BSPM) Receives Approval From Xianyang SFDA to Restart Sales of Its Gel Capsule Drugs More...

• Mylan Inc. (MYL) Launches Generic Version of Amidate&#0174 Injection More...

• Qualitest Pharmaceuticals Launches Generic Singulair&#0174 More...